Multiple Dose, Steady State-Partial reference replicate [Design Issues]

posted by ElMaestro  – Denmark, 2018-07-13 13:42 (1496 d 05:16 ago) – Posting: # 19047
Views: 3,572

Hi arl_stat,

» Please help in understanding whether it is possible to conduct “An open-label, randomized, Multiple Dose, Steady State, two treatments, three periods, three sequence, three way, Reference Replicated crossover bioequivalence study” for USFDA Submission?

Yes to everything except (conditionally) the term 'three way' in the context of your post.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
22,305 posts in 4,668 threads, 1,587 registered users;
online 15 (1 registered, 14 guests [including 10 identified bots]).
Forum time: Wednesday 18:59 CEST (Europe/Vienna)

There is no point in being precise when you don’t know
what you’re talking about.    attributed to John Tukey

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5